Tag: Tariffs
BioVoice eMagazine September 2025 | Issue 8 | Volume 6
The Cover Story focuses on the impact of massive tariffs levied by US admin under President, Donald Trump. This edition also features interview of Koji Wada, Managing Director, FUJIFILM India, along with the expert insights by Dr Ashish Gautam of Max Hospital and Vamsi Ravali Pattisapu of Tata Elxsi
Top 20 global biopharma companies report 5.7% fall in market capitalization...
Tariffs, pricing pressures erode $200 billion in value for top biopharma firms; Alnylam and Novartis buck the trend with strong gains
India’s pharma exports surpass USD 30 Billion in FY2025 and aim...
The Rubix report further points to a clear shift in strategic priorities among Indian pharma firms, particularly as global risks mount
Budget 2024: Healthcare industry welcomes custom duty exemptions on cancer medicines...
Read the detailed reactions from the stakeholders across various segments including medical technology, hospitals and diagnostics